Wealthcare Advisory Partners’s Meridian Bioscience Inc VIVO Stock Holding History

Wealthcare Advisory Partners’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-334	Closed	-$9K	–	2028
2021 Q1	$9K	Buy	+334	New	+$7.94K	﹤0.01%	1506
2020 Q2	–	Sell	-334	Closed	-$3K	–	1466
2020 Q1	$3K	Hold	334	–	–	﹤0.01%	1259
2019 Q4	$3K	Hold	334	–	–	﹤0.01%	1227
2019 Q3	$3K	Hold	334	–	–	﹤0.01%	1183
2019 Q2	$4K	Hold	334	–	–	﹤0.01%	1118
2019 Q1	$6K	Buy	334 +2	+0.6%	+$33	﹤0.01%	942
2018 Q4	$6K	Buy	332 +2	+0.6%	+$34	﹤0.01%	910
2018 Q3	$5K	Buy	330 +3	+0.9%	+$47	﹤0.01%	1013
2018 Q2	$5K	Buy	327 +3	+0.9%	+$45	﹤0.01%	1003
2018 Q1	$5K	Buy	324 +3	+0.9%	+$44	﹤0.01%	845
2017 Q4	$4K	Buy	321 +2	+0.6%	+$29	﹤0.01%	845
2017 Q3	$5K	Buy	+319	New	+$4.56K	﹤0.01%	665

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealthcare Advisory Partners's VIVO Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Meridian Bioscience Inc (VIVO) in Q2 2021, closing a stake of 334 shares — an estimated $9K sold.

Wealthcare Advisory Partners first reported a position in VIVO in Q3 2017 and held it in 12 quarters. The position peaked at $9K in Q1 2021. 189 funds tracked by Wall St. Rank hold VIVO as of Q2 2021.

Wealthcare Advisory Partners reported no remaining Meridian Bioscience Inc position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 334 Meridian Bioscience Inc shares in Q2 2021, an estimated $9K.
Wealthcare Advisory Partners first reported a position in Meridian Bioscience Inc in Q3 2017 and held it in 12 quarters.
Wealthcare Advisory Partners's Meridian Bioscience Inc position peaked at $9K in Q1 2021.
189 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.